FATE THERAPEUTICS INC financial data

Symbol
FATE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 751% % -11%
Return On Equity -55% % -11%
Return On Assets -38% % -3.9%
Operating Margin -2222% % -44%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 116,263,459 shares 1.5%
Common Stock, Shares, Outstanding 115,359,735 shares 1.3%
Entity Public Float $113,000,000 USD -69%
Common Stock, Value, Issued $115,000 USD 0.88%
Weighted Average Number of Shares Outstanding, Basic 118,789,974 shares 4.5%
Weighted Average Number of Shares Outstanding, Diluted 118,789,974 shares 4.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $6,646,000 USD -51%
Research and Development Expense $107,829,000 USD -20%
General and Administrative Expense $46,521,000 USD -37%
Operating Income (Loss) $147,704,000 USD 30%
Net Income (Loss) Attributable to Parent $136,315,000 USD 27%
Earnings Per Share, Basic -1.15 USD/shares 30%
Earnings Per Share, Diluted -1.15 USD/shares 30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $46,628,000 USD 29%
Accounts Receivable, after Allowance for Credit Loss, Current $916,000 USD -74%
Assets, Current $208,704,000 USD -29%
Property, Plant and Equipment, Net $56,925,000 USD -12%
Operating Lease, Right-of-Use Asset $41,609,000 USD -11%
Other Assets, Noncurrent $0 USD -100%
Assets $318,937,000 USD -28%
Accounts Payable, Current $2,656,000 USD -72%
Accrued Liabilities, Current $20,024,000 USD -6.2%
Contract with Customer, Liability, Current $381,000 USD -3.1%
Liabilities, Current $36,071,000 USD -6.4%
Operating Lease, Liability, Noncurrent $73,287,000 USD -5.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $116,000 USD -57%
Retained Earnings (Accumulated Deficit) $1,534,309,000 USD -9.8%
Stockholders' Equity Attributable to Parent $207,184,000 USD -35%
Liabilities and Equity $318,937,000 USD -28%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,809,000 USD -1.4%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $42,673,000 USD 146%
Common Stock, Shares Authorized 350,000,000 shares -86%
Common Stock, Shares, Issued 115,359,735 shares 1.3%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $8,864,000 USD -89%
Deferred Tax Assets, Valuation Allowance $387,974,000 USD 7.2%
Deferred Tax Assets, Gross $399,335,000 USD 6.7%
Operating Lease, Liability $77,849,000 USD -8.7%
Payments to Acquire Property, Plant, and Equipment $1,196,000 USD 1291%
Lessee, Operating Lease, Liability, to be Paid $119,303,000 USD -11%
Property, Plant and Equipment, Gross $93,148,000 USD -6.4%
Operating Lease, Liability, Current $4,562,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Two $11,382,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $11,050,000 USD -23%
Operating Lease, Weighted Average Discount Rate, Percent 0.085 pure 1.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $41,454,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $10,293,000 USD -9.6%
Deferred Tax Assets, Operating Loss Carryforwards $186,855,000 USD 27%
Preferred Stock, Shares Issued 2,761,108 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $82,410,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Four $10,602,000 USD 3%
Additional Paid in Capital $1,741,259,000 USD 1.5%
Preferred Stock, Shares Outstanding 2,761,108 shares
Depreciation, Depletion and Amortization $3,333,000 USD -31%
Share-based Payment Arrangement, Expense $24,924,000 USD -40%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%